Scurvy is still found in Canada

Scurvy is still found in Canada

Dog study suggests that AAV in gene therapy could induce cancer Among those with scurvy, some were related to alcohol use disorder or to bariatric surgery but the majority were related to other causes of malnutrition such as persistent vomiting, purposeful dietary restrictions, mental illness, social isolation and dependence on others for food. "Scurvy is seen as a disease irrelevant to the modern world, but it still exists, and clinicians caring for at-risk patients should be aware of it and know how to diagnose it," said John Neary, associate professor of medicine at McMaster and the senior author of the study published this month in the Journal of General Internal Medicine . First author Kayla Dadgar, who did the research as a medical student at McMaster, said: Scurvy should be a 'never event' in a healthy society. That it still occurs in Canada in our time indicates that we are not supporting vulnerable people as we should." The patients with scurvy who were given Vitamin C had a rapid recovery of their symptoms. Dadgar is now an internal medicine resident at the University of Ottawa. Source: McMaster University Journal reference: Dadgar, K & Neary, J . (2020) Clinical Profile of Scurvy in Hamilton Since 2009: a Cohort Study. Journal of General Internal Medicine . doi.org/10.1007/s11606-020-05636-1 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More